Cargando…

Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation

Albumin has shown remarkable promise as a natural drug carrier by improving pharmacokinetic (PK) profiles of anticancer drugs for tumor-targeted delivery. The exogenous or endogenous albumin enhances the circulatory half-lives of anticancer drugs and passively target the tumors by the enhanced perme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Hanhee, Jeon, Seong Ik, Ahn, Cheol-Hee, Shim, Man Kyu, Kim, Kwangmeyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028280/ https://www.ncbi.nlm.nih.gov/pubmed/35456562 http://dx.doi.org/10.3390/pharmaceutics14040728

Ejemplares similares

Cathepsin B-Overexpressed Tumor Cell Activatable Albumin-Binding Doxorubicin Prodrug for Cancer-Targeted Therapy
por: Cho, Hanhee, et al.
Publicado: (2021)

Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy
por: Moon, Yujeong, et al.
Publicado: (2023)

Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems
por: Yun, Wan Su, et al.
Publicado: (2023)

Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy
por: Kim, Jeongrae, et al.
Publicado: (2023)

Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy
por: Lim, Seungho, et al.
Publicado: (2019)

All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy
por: Song, Sukyung, et al.
Publicado: (2023)

Liposomal Drug Delivery Systems and Anticancer Drugs
por: Olusanya, Temidayo O. B., et al.
Publicado: (2018)

Overcoming anticancer resistance by photodynamic therapy-related efflux pump deactivation and ultrasound-mediated improved drug delivery efficiency
por: Kim, Doyeon, et al.
Publicado: (2020)

Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systems
por: Bajracharya, Rajiv, et al.
Publicado: (2022)

Nanotechnology in oncology: Characterization and in vitro release kinetics of cisplatin-loaded albumin nanoparticles: Implications in anticancer drug delivery
por: Das, Saikat, et al.
Publicado: (2011)

Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death
por: Moon, Yujeong, et al.
Publicado: (2022)

Targeted Delivery Methods for Anticancer Drugs
por: Veselov, Valery V., et al.
Publicado: (2022)

Theoretical aspects of interaction of the anticancer drug cytarabine with human serum albumin
por: Amirinasab, Maryam, et al.
Publicado: (2023)

Magnetite graphene oxide-albumin conjugate: carrier for the imatinib anticancer drug
por: Mashreghi, Maral, et al.
Publicado: (2023)

Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses
por: Kim, Jeongrae, et al.
Publicado: (2022)

Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy
por: Cho, Hanhee, et al.
Publicado: (2022)

Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery
por: Zheng, Yao-Rong, et al.
Publicado: (2014)

Albumin binding and anticancer effect of magnesium oxide nanoparticles
por: Behzadi, Elham, et al.
Publicado: (2018)

Uncovering the molecular and physiological processes of anticancer leads binding human serum albumin: A physical insight into drug efficacy
por: Liu, Chuanbo, et al.
Publicado: (2017)

Functionalized Graphene Platforms for Anticancer Drug Delivery
por: Sattari, Shabnam, et al.
Publicado: (2021)

Recent Advances in Polycaprolactones for Anticancer Drug Delivery
por: Bhadran, Abhi, et al.
Publicado: (2023)

Nanoparticle-based materials in anticancer drug delivery: Current and future prospects
por: Ajith, Saniha, et al.
Publicado: (2023)

Interactive Association of Drugs Binding to Human Serum Albumin
por: Yang, Feng, et al.
Publicado: (2014)

Early stage release control of an anticancer drug by drug-polymer miscibility in a hydrophobic fiber-based drug delivery system
por: Yuan, Yue, et al.
Publicado: (2018)

Pulmonary Drug Delivery of Antimicrobials and Anticancer Drugs Using Solid Dispersions
por: Al-Obaidi, Hisham, et al.
Publicado: (2021)

Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
por: Shim, Joong Sup, et al.
Publicado: (2014)

Correction: Uncovering the molecular and physiological processes of anticancer leads binding human serum albumin: A physical insight into drug efficacy
Publicado: (2017)

Albumin-based drug delivery: harnessing nature to cure disease
por: Larsen, Maja Thim, et al.
Publicado: (2016)

Nanocarriers for ocular drug delivery: current status and translational opportunity
por: Gorantla, Srividya, et al.
Publicado: (2020)

Challenges of Current Anticancer Treatment Approaches with Focus on Liposomal Drug Delivery Systems
por: Gyanani, Vijay, et al.
Publicado: (2021)

Pharmacokinetics of Peptide Mediated Delivery of Anticancer Drug Ellipticine
por: Ma, Weina, et al.
Publicado: (2012)

Carboxymethyl Hyaluronan-Stabilized Nanoparticles for Anticancer Drug Delivery
por: Woodman, Jessica L., et al.
Publicado: (2015)

Precision spherical nucleic acids for delivery of anticancer drugs
por: Bousmail, Danny, et al.
Publicado: (2017)

Milk Exosomes: Perspective Agents for Anticancer Drug Delivery
por: Sedykh, Sergey, et al.
Publicado: (2020)

Microwave-assisted delivery of an anticancer drug to cancer cells
por: Mazinani, Sina Atrin, et al.
Publicado: (2018)

Nanocarriers: A Reliable Tool for the Delivery of Anticancer Drugs
por: Sabit, Hussein, et al.
Publicado: (2022)

Hyaluronic Acid-Based Nanocarriers for Anticancer Drug Delivery
por: Fu, Chao-Ping, et al.
Publicado: (2023)

Computational approaches to delivery of anticancer drugs with multidimensional nanomaterials()
por: Shukla, Shubhangi, et al.
Publicado: (2023)

Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials
por: Bruinsmann, Franciele Aline, et al.
Publicado: (2019)

Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro
por: Olsen, Harald, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_qrgg3hdjogpta4qrd0m9nb6tq0